VOR
Vor Biopharma Inc
18.70$
+3.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +5.7% | -7.8% | -5.6% | +5.5% | -4.6% | +146.9% | -99.9% | -2,100.0% | – | +28.6% | – | |
| – | -40.1% | +62.7% | -9.3% | -18.9% | -24.5% | +13.1% | -4.6% | +335.4% | +11.5% | -0.9% | +6.0% | – | |
| – | -161.4% | – | – | -107.0% | – | -193.7% | – | +9.2% | -37.5% | -591.8% | – | – | |
| – | -76.1% | +2.7% | -92.1% | +277.8% | +111.8% | +220.8% | -34.2% | +60.5% | +28.7% | -84.7% | +150.0% | – | |
| – | -74.5% | +325.5% | +20.5% | -100.1% | +111.8% | +219.4% | – | -137.8% | +19,971.3% | +437.5% | -86.1% | – | |
| – | +9,900.0% | +727.3% | +0.0% | -33.5% | – | – | -41.8% | +131.3% | – | – | +100.0% | – | |
| – | -85.8% | +284.0% | -132.3% | – | +129,865.9% | -101.1% | – | -87.7% | +1,328.4% | -75.7% | -100.0% | – | |
| – | -206.6% | – | +128.7% | -174.8% | – | -209.4% | – | -123.1% | – | -195.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.